Home
/
AETHLON MEDICAL INC
/
Financials
/
Quarterly
AETHLON MEDICAL INC — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that AETHLON MEDICAL INC filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2023
Jun 30, 2022
$0
Aug 9, 2022
Q3
2022
Dec 31, 2021
$17.1K
Feb 14, 2022
Q2
2022
Sep 30, 2021
$132.0K
Nov 9, 2021
Q1
2023
Jun 30, 2021
$132.0K
Aug 9, 2022
Q3
2022
Dec 31, 2020
$624.9K
Feb 14, 2022
Q2
2022
Sep 30, 2020
$0
Nov 9, 2021
Q1
2021
Jun 30, 2020
$0
Aug 9, 2021
Q3
2021
Dec 31, 2019
$413.5K
Feb 10, 2021
Q2
2021
Sep 30, 2019
$0
Oct 28, 2020
Q1
2021
Jun 30, 2019
$30.0K
Aug 11, 2020
Q3
2020
Dec 31, 2018
$0
Feb 10, 2020
Q2
2020
Sep 30, 2018
$0
Nov 1, 2019
Q1
2020
Jun 30, 2018
$149.6K
Aug 14, 2019
Q3
2019
Dec 31, 2017
$74.8K
Feb 11, 2019
Q2
2019
Sep 30, 2017
$0
Nov 6, 2018
Q1
2019
Jun 30, 2017
$0
Aug 8, 2018
Q3
2018
Dec 31, 2016
$392.1K
Feb 1, 2018
Q2
2018
Sep 30, 2016
$392.1K
Nov 2, 2017
Q1
2018
Jun 30, 2016
$4.6K
Aug 10, 2017
Q3
2015
Dec 31, 2014
$33.4K
Feb 10, 2015
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2023
Dec 31, 2022
$0
Feb 13, 2023
Q2
2022
Sep 30, 2022
$0
Nov 14, 2022
Q1
2023
Jun 30, 2022
$0
Aug 9, 2022
Q3
2023
Dec 31, 2021
$17.1K
Feb 13, 2023
Q2
2022
Sep 30, 2021
$132.0K
Nov 14, 2022
Q1
2023
Jun 30, 2021
$132.0K
Aug 9, 2022
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2018
Jun 30, 2017
$0
Aug 10, 2017
Q1
2018
Jun 30, 2016
$4.6K
Aug 10, 2017
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2026
Dec 31, 2025
($2.02M)
Feb 12, 2026
Q3
2026
Sep 30, 2025
($1.49M)
Feb 12, 2026
Q2
2026
Sep 30, 2025
($1.49M)
Nov 12, 2025
Q1
2026
Jun 30, 2025
($1.76M)
Aug 13, 2025
Q3
2026
Jun 30, 2025
($1.76M)
Feb 12, 2026
Q2
2026
Jun 30, 2025
($1.76M)
Nov 12, 2025
Q3
2026
Dec 31, 2024
($1.75M)
Feb 12, 2026
Q2
2026
Sep 30, 2024
($2.81M)
Nov 12, 2025
Q3
2026
Sep 30, 2024
($2.81M)
Feb 12, 2026
Q1
2026
Jun 30, 2024
($2.57M)
Aug 13, 2025
Q2
2026
Jun 30, 2024
($2.57M)
Nov 12, 2025
Q3
2026
Jun 30, 2024
($2.57M)
Feb 12, 2026
Q3
2025
Dec 31, 2023
($3.47M)
Feb 12, 2025
Q2
2025
Sep 30, 2023
($3.03M)
Nov 13, 2024
Q3
2025
Sep 30, 2023
($3.03M)
Feb 12, 2025
Q3
2025
Jun 30, 2023
($3.28M)
Feb 12, 2025
Q1
2025
Jun 30, 2023
($3.28M)
Aug 14, 2024
Q3
2024
Dec 31, 2022
($2.85M)
Feb 14, 2024
Q2
2024
Sep 30, 2022
($3.81M)
Nov 14, 2023
Q1
2023
Jun 30, 2022
($2.91M)
Aug 10, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2026
Dec 31, 2025
($2.06M)
Feb 12, 2026
Q2
2026
Sep 30, 2025
($1.51M)
Nov 12, 2025
Q1
2026
Jun 30, 2025
($1.79M)
Aug 13, 2025
Q3
2026
Dec 31, 2024
($1.81M)
Feb 12, 2026
Q2
2026
Sep 30, 2024
($2.90M)
Nov 12, 2025
Q1
2026
Jun 30, 2024
($2.62M)
Aug 13, 2025
Q3
2025
Dec 31, 2023
($3.57M)
Feb 12, 2025
Q2
2025
Sep 30, 2023
($3.18M)
Nov 13, 2024
Q1
2025
Jun 30, 2023
($3.41M)
Aug 14, 2024
Q3
2024
Dec 31, 2022
($2.85M)
Feb 14, 2024
Q2
2024
Sep 30, 2022
($3.67M)
Nov 14, 2023
Q1
2023
Jun 30, 2022
($2.91M)
Aug 10, 2023
Q3
2023
Dec 31, 2021
($2.53M)
Feb 13, 2023
Q2
2022
Sep 30, 2021
($2.01M)
Nov 14, 2022
Q1
2023
Jun 30, 2021
($2.10M)
Aug 9, 2022
Q3
2022
Dec 31, 2020
($2.44M)
Feb 14, 2022
Q2
2022
Sep 30, 2020
($1.77M)
Nov 9, 2021
Q1
2021
Jun 30, 2020
($1.41M)
Aug 9, 2021
Q3
2021
Dec 31, 2019
($876.4K)
Feb 10, 2021
Q2
2021
Sep 30, 2019
($1.70M)
Oct 28, 2020